Abstracts Archive - Page 1792 of 2425 - ACR Meeting Abstracts

Abstract Number: 1544 • 2015 ACR/ARHP Annual Meeting
Resiliency As a Predictor of Depressive Symptoms in Patients with Rheumatoid Arthritis
Matt Woo¹, Nadil Zeiadin¹, Hayley Yurgan², Dean Tripp³ and Mala Joneja¹, ¹Medicine, Queen's University, Kingston, ON, Canada, ²Psychology, Queen's University, Kingston, ON, Canada, ³Psychology, Anaesthesiology, Urology, Queen's University, Kingston, ON, Canada
Background/Purpose: Rheumatoid arthritis is a chronic, systemic, autoimmune disease affecting 0.5 – 1% of the adult population that leads to a progressive decline in functional…
Abstract Number: 1545 • 2015 ACR/ARHP Annual Meeting
Comparison of Statin Eligibility According to the Adult Treatment Panel III, ACC/AHA Blood Cholesterol Guideline and Presence of Carotid Plaque By Ultrasound in Hispanics with Rheumatoid Arthritis
Alberto Cardenas-de La Garza¹, Raymundo Vera-Pineda², Dionicio A. Galarza-Delgado¹, Jose Ramon Azpiri-Lopez³, Iris J. Colunga-Pedraza¹, Jesus Zacarias Villarreal-Pérez⁴, Griselda Serna-Peña⁵ and Mario Alberto Garza-Elizondo¹, ¹Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, ²Cardiology., Hospital Universitario, UANL., Monterrey, Mexico, ³Cardiology, Hospital Universitario, UANL., Monterrey, Mexico, ⁴Endocrinology, Hospital Universitario, UANL., Monterrey, Mexico, ⁵Internal Medicine, Hospital Universitario, UANL., Monterrey, Mexico
Background/Purpose: Atherosclerotic cardiovascular disease (ASCVD) is the number one cause of death in rheumatoid arthritis (RA) patients. RA itself is an independent risk factor for…
Abstract Number: 1546 • 2015 ACR/ARHP Annual Meeting
What Is the Impact of Smoking on the Risk of Rheumatoid Arthritis Progression: A Systematic Review of the Risk Factor Paradox
Sharan K. Rai¹, Natalie McCormick², Uyen Sa D.T. Nguyen³, Yuqing Zhang⁴, Jeffrey A. Sparks⁵, Elizabeth W. Karlson⁶ and Hyon K. Choi⁷, ¹Experimental Medicine, University of British Columbia, Vancouver, BC, Canada, ²Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, ³Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, ⁴Clinical Epidemilogy and Training Unit, Boston University School of Medicine, Boston, MA, ⁵Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA, ⁶Rheumatology, Brigham & Women's Hospital, Boston, MA, ⁷Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease that leads to progressive joint deformity, destruction, and disability. While smoking is recognized as a strong…
Abstract Number: 1547 • 2015 ACR/ARHP Annual Meeting
Implementing an Electronic Medical Recorded-Based Clinical Decision Support Tool Did Not Improve Cardiovascular Risk Screening in Rheumatoid Arthritis Patients
Anand Kumthekar¹, Michail Alevizos², Nicole Jordan³ and Anna R. Broder⁴, ¹Medicine, Albert Einstein College of Medicine/Jacobi Medical Center, Bronx, NY, ²Medicine, Albert Einstien College of Medicine/Jacobi Medical Center, Bronx, NY, ³Montefiore Medical Center, New York, NY, ⁴Rheumatology-Forchheimer 701N, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
Background/Purpose: Cardiovascular disease (CVD) is the leading cause of death among individuals with rheumatoid arthritis (RA). The 2010 EULAR guidelines recommend annual CV risk assessment…
Abstract Number: 1548 • 2015 ACR/ARHP Annual Meeting
Comparison of 5 Cardiovascular Risk Calculators in a Hispanic Rheumatoid Arthritis Cohort
Alberto Cardenas-de La Garza¹, Raymundo Vera-Pineda², Dionicio A. Galarza-Delgado¹, Jose Ramon Azpiri-Lopez³, Iris J. Colunga-Pedraza¹, Griselda Serna-Peña⁴ and Mario Alberto Garza-Elizondo¹, ¹Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, ²Cardiology., Hospital Universitario, UANL., Monterrey, Mexico, ³Cardiology, Hospital Universitario, UANL., Monterrey, Mexico, ⁴Internal Medicine, Hospital Universitario, UANL., Monterrey, Mexico
Background/Purpose: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in RA. Management and stratification of ASCVD in RA patients is still a matter…
Abstract Number: 1549 • 2015 ACR/ARHP Annual Meeting
Prevalence of Co-Morbidities and Evaluation of Their Monitoring in Korean Patients with RA: Comparison with the Results of an International, Cross-Sectional Study (COMORA)
In Ah Choi¹, Sung-Hwan Park², Hoon-Suk Cha³, Won Park⁴, Hyun Ah Kim⁵, Dae-Hyun Yoo⁶, Han Joo Baek⁷, SeungGeun Lee⁸, Yoon Jong Lee⁹, Yong Bum Park¹⁰, Seung-Cheol Shim¹¹, Ihsane Hmamouchi¹² and Yeong Wook Song¹³, ¹Rheumatology, Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, ²Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, Seoul, South Korea, ³Division of Rheumatology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, ⁴Division of Rheumatology, Department of Internal Medicine, Inha University Hospital, Incheon, South Korea, ⁵Division of Rheumatology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, South Korea, ⁶Division of Rheumatology, Department of Internal Medicine, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ⁷Rheumatology, Gachon University Gil Medical Center, Incheon, South Korea, ⁸Division of Rheumatology, Department of Internal Medicine, Pusan Nationl University Hospital, Busan, South Korea, ⁹Division of rheumatology Seoul National University Bundang Hospital, Seongnam, South Korea, ¹⁰Division of Rheumatology, Department of Internal Medicine, Yoesei University Severance Hospital, Seoul, South Korea, ¹¹Division of Rheumatology, Department of Internal Medicine, Eulji University Hospital, Daejeon, South Korea, ¹²El Ayachi Hospital, Rabat, Morocco, ¹³Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
Background/Purpose: Rheumatoid Arthritis (RA) patients are at increased risk of developing co-morbid conditions. We designed this study to evaluate the prevalence of comorbidities and their…
Abstract Number: 1550 • 2015 ACR/ARHP Annual Meeting
Flares of Disease Activity As Risk Factor for the Occurrence of Myocardial Infarction in Patients with Rheumatoid Arthritis
Esmee Bakker¹, Pauline Geuijen², Beata Radovits¹, Delia Popa-Diaconu¹, Calin Popa¹, Elke Arts¹, Alfons A. den Broeder³ and Jaap Fransen¹, ¹Rheumatology, Radboud University Medical Centre, Nijmegen, Netherlands, ²Rheumatology, Radboud University Medical Center, Nijmegen, Netherlands, ³Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands
Background/Purpose: Rheumatoid arthritis (RA) patients have an increased risk of cardiovascular diseases (CVD). The underlying mechanism is partly explained by the inflammation process in both…
Abstract Number: 1551 • 2015 ACR/ARHP Annual Meeting
Rheumatoid Vasculitis: A Decline in the XXI Century
Anne Riveros Frutos, Melania Martínez-Morillo, Samantha Rodriguez-Muguruza, Juana Sanint, Agueda Prior, Jeronima Cañellas, Susana Holgado, Maria Lourdes Mateo, Xavier Tena and Alejandro Olivé, Rheumatology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
Background/Purpose: Rheumatoid vasculitis is an extra articular manifestation of rheumatoid arthritis (RA), that occurs during the course of long standing disease. It is associated with…
Abstract Number: 1552 • 2015 ACR/ARHP Annual Meeting
Illness Perceptions in Rheumatoid Arthritis: A Comparison of Canadian and Nigerian Patients
Susan J. Bartlett¹, Olufemi Adelowo², Maria Celia Bazan Bardales³ and Ines Colmegna⁴, ¹Medicine , Divisions of Clinical Epidemiology, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, ²Rheumatology, Arthrimed Specialist Clinic, Lagos, Nigeria, ³Rheumatology, McGill University, Montreal, QC, Canada, ⁴McGill University, Montreal, QC, Canada
Background/Purpose: Illness perceptions (IP) are the beliefs and expectations that an individual has about medical conditions. IP cluster around five coherent themes and provide a…
Abstract Number: 1553 • 2015 ACR/ARHP Annual Meeting
Effect of Drug Therapy on Net Cholesterol Efflux Capacity of HDL-Enriched Serum in Rheumatoid Arthritis
Michelle J. Ormseth¹, S. Louis Bridges Jr.², Jeffrey R. Curtis³, Joseph F. Solus⁴, Patricia Yancey⁵, MacRae F. Linton⁶, Sean Davies⁶, L Jackson Roberts II⁷, Kasey C. Vickers⁶, Valentina Kon⁶, Sergio Fazio⁸, C Michael Stein⁶ and TETRAD Investigators, ¹Department of Medicine, Division of Rheumatology, Vanderbilt University, Nashville, TN, ²Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ³University of Alabama at Birmingham, Birmingham, AL, ⁴Clinical Pharmacology, Vanderbilt University, Nashville, TN, ⁵Medicine, Vanderbilt University, Nashville, TN, ⁶Vanderbilt University, Nashville, TN, ⁷Pharmacology, Vanderbilt University, Nashville, TN, ⁸Oregon Health and Science University, Portland, OR
Background/Purpose: Patients with rheumatoid arthritis (RA) have increased coronary heart disease risk. Some RA therapies may modify this risk, but underlying mechanisms are unclear. The…
Abstract Number: 1554 • 2015 ACR/ARHP Annual Meeting
Severe Pneumonia after a 13-Prevalent Pneumonoccal Conjugate Vaccine (Prevena 13) Among Patients with Rheumatoid Arthritis
Sung Hae Chang¹ and Seong-Su Nah², ¹internal medicine, seoul national university, seoul, South Korea, ²Soonchunhyang clinical medical research center, Department of Soonchunhyang clinical medical research center, Choenan, South Korea
Background/Purpose: Disease modifying anti-rheumatic drugs (DMARDs) including methotrexate (MTX) and biologics were ported to attenuate response to a previous 23-prevalent pneumococcal polysaccharide vaccine. Recently, a…
Abstract Number: 1555 • 2015 ACR/ARHP Annual Meeting
Geography and the Influence of Comorbidity on the Prevalence of Depression in Patients with Rheumatoid Arthritis,a Study Across Seventeen Countries
Raluca Dumitru¹, Elizabeth M.A. Hensor², Ihsane Hmamouchi³, Paul Emery², Maxime Dougados⁴ and Maya H. Buch⁵, ¹University of Leeds, Leeds Institute of Molecular Medicine and LMBRU, Leeds, United Kingdom, ²Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, ³El Ayachi Hospital, Rabat, Morocco, ⁴Service de Rhumatologie B, GHU Cochin, F-75014 France, PARIS, France, ⁵Division of Rheumatic and Musculoskeletal Disease, University of Leeds, Leeds Institute of Molecular Medicine and LMBRU, Leeds, United Kingdom
Background/Purpose: Comorbidities represent a major challenge for patients with rheumatoid arthritis. Depression is one of the most common comorbidities with prevalence up to 38%. Disease…
Abstract Number: 1556 • 2015 ACR/ARHP Annual Meeting
The Medication Information-Seeking Behaviors of Rheumatoid Arthritis Patients Who Are Prescribed a New DMARD
Delesha Carpenter¹, Lorie Geryk², Courtney Arrindell³, Beth Jonas⁴ and Susan J. Blalock⁵, ¹Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Asheville, NC, ²Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, ³University of North Carolina at Chapel Hill, Chapel Hill, NC, ⁴Thurston Arthritis Research Ct, UNC-Chapel Hill, Chapel Hill, NC, ⁵School of Pharmacy, UNC at Chapel Hill, Chapel Hill, NC
Background/Purpose: We present preliminary longitudinal data about the information-seeking behaviors and medication experiences of RA patients who are prescribed a new DMARD. Methods: We recruited…
Abstract Number: 1557 • 2015 ACR/ARHP Annual Meeting
The Impact of Hindfoot Deformity on Disability of Korean Patients with Rheumatoid Arthritis
Hye-Jin Jeong¹, Il Woong Sohn¹, Seung Lee¹, Seung Taek Song¹, Soo-Kyung Cho² and Yoon-Kyoung Sung², ¹Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ²Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea
Background/Purpose: Rheumatoid arthritis (RA) commonly involves the hindfoot, but this part is frequently overlooked when caring for patients with multiple joints pain and deformity. For…
Abstract Number: 1558 • 2015 ACR/ARHP Annual Meeting
Serum Cathepsin S and Cystatin C Relation with Carotid Subclinical Atheromatosis in Rheumatoid Arthritis Patients
Beatriz Tejera Segura¹, De Vera-González AM², Raquel López-Mejías³, Miguel A. Gonzalez-Gay⁴ and Ivan Ferraz-Amaro¹, ¹Division of Rheumatology, University Hospital of Canary Islands, Tenerife, Spain, ²Central Laboratory Division, University Hospital of Canary Islands, Tenerife, Spain, ³Rheumatology, Hospital Universitario Marqués de Valdecilla. IFIMAV, Santander, Spain, ⁴Reumatologia, Hospital Universitario Marqués de Valdecilla, IDIVAL, University of Cantabria, Santander, Spain
Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increased cardiovascular risks. Cathepsin S, a cysteine protease implicated in intracellular and extracellular proteolysis,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].